دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
A new era for Africa CDC
doi : 10.1016/S0140-6736(23)01887-1
Volume 402, Issue 10405, 9–15 September 2023, Page 825
Adding a COX-2 inhibitor improves efficacy of emergency contraception
Erica P Cahill
doi : 10.1016/S0140-6736(23)01612-4
Volume 402, Issue 10405, 9–15 September 2023, Pages 826-827
Phase 3 trial results bring hope for patients with IgA nephropathy
B?rje Haraldsson
doi : 10.1016/S0140-6736(23)01633-1
Volume 402, Issue 10405, 9–15 September 2023, Pages 827-829
Safe and effective systemic therapy for early-stage non-small-cell lung cancer
Eric D Brooks
doi : 10.1016/S0140-6736(23)01464-2
Volume 402, Issue 10405, 9–15 September 2023, Pages 829-831
Universal free school meals: the future of school meal programmes?
Juliana F W Cohen, Stéphane Verguet, Boitshepo Bibi Giyose, Donald Bundy
doi : 10.1016/S0140-6736(23)01516-7
Volume 402, Issue 10405, 9–15 September 2023, Pages 831-833
Structural racism and iron deficiency anaemia
*Ian Roberts, Camara Phyllis Jones
doi : 10.1016/S0140-6736(23)01350-8
Volume 402, Issue 10405, 9–15 September 2023, Pages 834-835
Offline: A job is important, but so is life
Richard Horton
doi : 10.1016/S0140-6736(23)01882-2
Volume 402, Issue 10405, 9–15 September 2023, Page 836
Ukrainian medic prisoners of war speak out
Ed Holt
doi : 10.1016/S0140-6736(23)01885-8
Volume 402, Issue 10405, 9–15 September 2023, Pages 837-838
More US states ban teenagers' gender-affirming care
Susan Jaffe
doi : 10.1016/S0140-6736(23)01886-X
Volume 402, Issue 10405, 9–15 September 2023, Pages 839-840
Femi Oyebode: entering into the human story
Aarathi Prasad
doi : 10.1016/S0140-6736(23)01838-X
Volume 402, Issue 10405, 9–15 September 2023, Page 841
Pharmacovigilance against racial capitalism
Harriet A Washington
doi : 10.1016/S0140-6736(23)01848-2
Volume 402, Issue 10405, 9–15 September 2023, Pages 842-843
Kamran Rafiq
Andrew Green
doi : 10.1016/S0140-6736(23)01849-4
Volume 402, Issue 10405, 9–15 September 2023, Page 844
Discrimination, feeling undervalued, and health-care workforce attrition: an analysis from the UK-REACH study
Christopher A Martin, Asta Medisauskaite, Mayuri Gogoi, Lucy Teece, Joshua Nazareth, Daniel Pan, Sue Carr, Kamlesh Khunti, Laura B Nellums, Katherine Woolf, *Manish Pareek, on behalf of the UK-REACH Study Collaborative Group
doi : 10.1016/S0140-6736(23)01365-X
Volume 402, Issue 10405, 9–15 September 2023, Pages 845-848
Sudan's maternal health needs urgent attention amid armed conflict
Sefiu Olalekan Olaleye, Temitope Folashade Aroyewun, Reem Abdelrahman Osman
doi : 10.1016/S0140-6736(23)01697-5
Volume 402, Issue 10405, 9–15 September 2023, Pages 848-849
The promise of peace talks for Yemen's health-care system
Yasir Alshareefy
doi : 10.1016/S0140-6736(23)01371-5
Volume 402, Issue 10405, 9–15 September 2023, Page 849
Pakistan's economic and health crisis: calls for urgent action
Yumna Khabir
doi : 10.1016/S0140-6736(23)00566-4
Volume 402, Issue 10405, 9–15 September 2023, Pages 849-850
Department of Error
doi : 10.1016/S0140-6736(23)01851-2
Volume 402, Issue 10405, 9–15 September 2023, Page 850
Department of Error
doi : 10.1016/S0140-6736(23)01852-4
Volume 402, Issue 10405, 9–15 September 2023, Page 850
Department of Error
doi : 10.1016/S0140-6736(23)01850-0
Volume 402, Issue 10405, 9–15 September 2023, Page 850
Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial
Raymond Hang Wun Li, Sue Seen Tsing Lo, Kristina Gemzell-Danielsson, Carol Ho Yi Fong, Pak Chung Ho, Ernest Hung Yu Ng
doi : 10.1016/S0140-6736(23)01240-0
Volume 402, Issue 10405, 9–15 September 2023, Pages 851-858
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimir Tesa?, Hern?n Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N Reich, Brad H Rovin, Jonathan Barratt, on behalf of the NefIgArd trial investigators
doi : 10.1016/S0140-6736(23)01554-4
Volume 402, Issue 10405, 9–15 September 2023, Pages 859-870
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Joe Y Chang, Steven H Lin, Wenli Dong, Zhongxing Liao, Saumil J Gandhi, Carl M Gay, Jianjun Zhang, Stephen G Chun, Yasir Y Elamin, Frank V Fossella, George Blumenschein, Tina Cascone, Xiuning Le, Jenny V Pozadzides, Anne Tsao, Vivek Verma, James W Welsh, Aileen B Chen, Mehmet Altan, Reza J Mehran, Ara A Vaporciyan, Stephen G Swisher, Peter A Balter, Junya Fujimoto, Ignacio I Wistuba, Lei Feng, J Jack Lee, John V Heymach
doi : 10.1016/S0140-6736(23)01384-3
Volume 402, Issue 10405, 9–15 September 2023, Pages 871-881
Pericardial-oesophageal fistula after ablation for atrial fibrillation
Yuhi Fujimoto, Yu-ki Iwasaki, Kuniya Asai
doi : 10.1016/S0140-6736(23)01675-6
Volume 402, Issue 10405, 9–15 September 2023, Page 882
The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action
Eloi Marijon, Kumar Narayanan, Karen Smith, Sérgio Barra, Cristina Basso, Marieke T Blom, Lia Crotti, Andre D’Avila, Rajat Deo, Florence Dumas, Anastase Dzudie, Audrey Farrugia, Kaitlyn Greeley, Gerhard Hindricks, Wei Hua, Jodie Ingles, Taku Iwami, Juhani Junttila, Rudolph W Koster, Jean-Benoît Le Polain De Waroux, Theresa M Olasveengen, Marcus E H Ong, Michael Papadakis, Comilla Sasson, Sang Do Shin, Hung-Fat Tse, Zian Tseng, Christian Van Der Werf, Fredrik Folke, Christine M Albert, Bo Gregers Winkel
doi : 10.1016/S0140-6736(23)00875-9
Volume 402, Issue 10405, 9–15 September 2023, Pages 883-936
